Hutch News

Hutch News

Stories tagged 'Human Herpes Viruses'

Experimental herpes drug more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows

Dec. 20, 2016 | By Mary Engel / Fred Hutch News Service

The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 19, 2015 | By Fred Hutch News Service staff

More than a dozen Fred Hutch scientists and staff participated in the ninth annual Life Sciences Research Weekend Nov. 6-8 at Pacific Science Center in Seattle. Read about this and more Good News at Fred Hutch.

View story >


Halting herpes' transmission

New Hutch study predicts threshold of viral load for passing herpes from one person to another

March 25, 2014 | By Mary Engel

Fred Hutch researchers used mathematical models to predict viral loads below which transmission of the herpes virus is unlikely to occur. Preventing transmission is critical because there is no cure for herpes.

View story >


Stemming the spread of STD's

International center-led trial finds that a daily dose of an antiviral drug halves transmission of genital herpes, may lessen other STD infections

Jan. 8, 2004

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.